AutoInflammatory Disease Alliance Registry (AIDA) (AIDA)
Development of an International Multicenter Registry of Patients With Monogenic and Polygenic Autoinflammatory Diseases Aimed at Clinical and Therapeutical Data Collection and Analysis
Sponsor: University of Siena
Listed as NCT05200715, this observational or N/A phase trial focuses on Autoinflammatory Syndrome, Unspecified and Behcet Syndrome and remains actively recruiting participants. Sponsored by University of Siena, it has been updated 8 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Aug 2025 — Sep 2025 [monthly]
Recruiting
-
May 2025 — Aug 2025 [monthly]
Recruiting
-
Sep 2024 — May 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Mar 2023 — Jul 2024 [monthly]
Recruiting
-
Sep 2022 — Mar 2023 [monthly]
Recruiting
-
Feb 2022 — Sep 2022 [monthly]
Recruiting
First recorded
Aug 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Siena
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Adana, Turkey (Türkiye) , Adelaide, Australia , Al Mansurah, Egypt , Algiers, Algeria , Ankara, Turkey (Türkiye) , Antwerp, Belgium , Athens, Greece , Bangalore, India , Barakaldo, Spain , Barcelona, Spain and 55 more locations